Furthermore, we compared its impact in haematological diseases with somatic TET2 mutations, including their mutation sites, variant allele frequency (VAF), diagnosis distributions, blood cell counts, prognosis, and survival. This evidence concerns the gene TET2 and hematologic disorder.